logologo
Search stocks, ETFs, IPOs & more
Quest
arrow
WhatsApp Icon

Colgate-Palmolive India Q1 FY27 results on Jul 29, 2026

COLPAL

Colgate-Palmolive (India) Ltd

COLPAL

Ask AI

Ask AI

Board meeting and results date

Colgate-Palmolive (India) Limited has scheduled a Board of Directors meeting for Wednesday, July 29, 2026, to consider and approve its unaudited financial results for the first quarter ended June 30, 2026. The company disclosed that the board meeting is meant to review Q1 FY27 performance, marking the start of the new financial year’s quarterly reporting cycle.

The July 29 board meeting is not a standalone event on the corporate calendar. It coincides with the company’s 85th Annual General Meeting (AGM), which is also scheduled for July 29, 2026.

85th AGM: timing and key matters

The 85th AGM will be held at 3:30 p.m. IST via video-conferencing and other audio-visual means (VC/OAVM). Along with routine matters such as adopting the FY26 financial statements, the AGM agenda includes key resolutions.

One of the highlighted items is the proposed five-year re-appointment of CFO Jacob Sebastian Madukkakuzy. The AGM and the board meeting being on the same day keeps focus on both near-term quarterly performance and longer-term governance and leadership continuity.

What the company reported for FY26

For the quarter ended March 31, 2026 (Q4 FY26), the company reported net sales of ₹1,582.77 crore, up 9% year-on-year from ₹1,452.02 crore in Q4 FY25. On a sequential basis, net sales rose 7.46% from ₹1,472.92 crore in Q3 FY26.

Total income for Q4 FY26 came in at ₹1,612.22 crore, an 8.82% increase from ₹1,481.57 crore in Q4 FY25 and a 5.69% increase from ₹1,525.41 crore in Q3 FY26. Net profit for Q4 FY26 was ₹353.32 crore, up 9.10% quarter-on-quarter from ₹323.86 crore in Q3 FY26, and slightly lower than ₹355.00 crore in Q4 FY25.

For the full year ended March 31, 2026 (FY26), net profit was ₹1,325.31 crore, down from ₹1,436.81 crore in FY25. FY26 net sales were ₹5,983.57 crore versus ₹5,999.20 crore in FY25, a marginal decline of 0.3%. Annual EPS for FY26 was ₹48.73 compared with ₹52.83 in FY25.

Q2 FY26: GST transition and profit pressure

Investor attention has remained high on Colgate-Palmolive (India)’s operating environment after its September quarter performance. The company reported Q2 net profit at ₹328 crore, down 17% year-on-year, and revenue down 6% to ₹1,507 crore.

The decline was attributed to changes in Goods and Services Tax (GST) rates affecting oral care products. As reported, GST on the company’s entire oral care portfolio was reduced from 18% to 5%, a transition that coincided with weaker topline and profitability in that quarter. Following the results, the stock was reported to have slid about 4%, and some brokerages trimmed target prices.

Dividend track record in FY26

Colgate-Palmolive (India) also announced dividend actions during FY26. The company fixed November 3, 2025 as the record date for dividend payment relating to the first interim dividend.

It declared a first interim dividend of ₹24 per equity share (face value Re 1) for FY 2025-26, with payment stated to be on and from November 19, 2025. The board later declared a second interim dividend of ₹24 per equity share for FY25-26, taking the total dividend for the year 2025-26 to ₹48 per share.

Earlier board meeting dates disclosed

Across the fiscal year, the company disclosed multiple board meeting dates linked to financial approvals. A board meeting was scheduled on October 23, 2025 to consider and approve unaudited financial results for the period ended September 30, 2025 and dividend.

Another board meeting was scheduled on January 29, 2026, inter alia, to consider and approve unaudited financial results for the quarter ended December 31, 2025. These disclosures provide context for how the company has sequenced results and shareholder actions through the year.

Snapshot of quarterly metrics available

The following company-provided quarterly table (figures in ₹ crore, except per share values) shows a quarter-ended June 2025 comparison on a QoQ basis.

MetricJun 25Mar 26QoQ Comp
Total Revenue1,434.061,595.35-1.95%
Total Operating Expense1,019.031,137.381.61%
Operating Income415.03457.97-9.71%
Net Income320.62353.32-9.68%
Net Income Before Taxes431.95474.03-9.56%
Depreciation/ Amortization37.5435.08-2.16%
Selling/ General/ Admin Expenses Total306.61319.856.52%
Diluted Normalized EPS11.7913.44-9.70%

Market context: price points cited in disclosures

Market data points referenced alongside the corporate updates included a reported “Today” price of ₹2,025.35 (updated Thu, 9 Jul 2026 at 11:16:30). Other cited levels included ₹2,044.85 (up ₹24.50 or 1.21%) and ₹2,042.50 (up ₹22.40 or 1.11%).

Separately, during the June 2025 quarterly coverage, shares were reported trading at ₹2,390 apiece at 2:13 pm on the BSE on that day. These price references indicate that the stock has been actively tracked around result events, dividend announcements, and regulatory disclosures.

Why the July 29 event matters for investors

The July 29, 2026 board meeting is expected to formally place Q1 FY27 numbers on record, which will be watched in the context of prior-quarter volatility. Recent quarters have shown a mix of topline growth periods and quarters affected by operating conditions and tax-linked transitions.

The same-day AGM adds another layer of significance, as shareholders will also vote on resolutions tied to governance and leadership, including the proposed re-appointment of the CFO for five years. Together, the two events set the stage for how investors assess both the operating trend entering FY27 and management continuity.

Conclusion

Colgate-Palmolive (India) is set to review and approve unaudited Q1 FY27 financial results on July 29, 2026, the same day it hosts its 85th AGM via VC/OAVM at 3:30 p.m. IST. Investors will track the update against FY26’s full-year profit decline, quarter-to-quarter movements in sales and profit, and the earlier GST-driven disruption cited around Q2 FY26. The next concrete milestone is the outcome of the board meeting and the AGM resolutions scheduled for July 29.

Frequently Asked Questions

The board meeting to consider and approve unaudited Q1 FY27 results is scheduled for July 29, 2026, for the quarter ended June 30, 2026.
The 85th AGM is scheduled for July 29, 2026 at 3:30 p.m. IST and will be held via VC/OAVM (video-conferencing/other audio-visual means).
Q4 FY26 net sales were ₹1,582.77 crore and net profit was ₹353.32 crore, as disclosed in the company’s results for the quarter ended March 31, 2026.
The company cited GST rate changes affecting oral care products; GST on its oral care portfolio was reduced from 18% to 5%, and Q2 FY26 PAT fell 17% YoY with revenue down 6%.
It declared a first interim dividend of ₹24 per share and later a second interim dividend of ₹24 per share, taking total dividend for FY25-26 to ₹48 per share; the record date mentioned for dividend payment was November 3, 2025.

Did your stocks survive the war?

See what broke. See what stood.

Live Q1 Earnings Tracker